Recently, Beijing Succeeder Technology Inc. (stock code: 688338), leveraging its industry influence and excellent reputation in the field of in vitro diagnostics for thrombosis and hemostasis, officially passed the review of the Beijing Chamber of International Commerce and was awarded a membership certificate. This serves as an important bridge for the company to expand international cooperation and connect with industry resources.

As a company listed on the STAR Market, SUCCEEDER has been deeply involved in the industry for over 20 years, focusing on the research, development, production, and sales of diagnostic instruments and related reagents for thrombosis and hemostasis. Its products cover half of the tertiary hospitals in China and are exported to more than 50 countries and regions.

The Beijing Chamber of International Commerce is an authoritative platform that brings together high-quality enterprises from multiple fields, helping companies expand their markets through cross-border trade and economic cooperation, industry exchanges, and other activities. This membership is both a recognition of SUCCEEDER’s industry position by the Chamber and injects new vitality into the Chamber’s ecosystem in the biomedical field.

In the future, SUCCEEDER will fully utilize the Chamber of Commerce’s global resource network, deeply participate in international economic and trade exchanges and industrial collaboration, continuously export high-quality domestically produced diagnostic products and solutions, promote technological progress in the industry, and contribute to the development of the medical and health industry.